In this session, Thermo Fisher's clinical ancillary management (CAM) subject matter expert will share how their services support patient-first readiness, reduce supply-related delays, and adapt to the evolving needs of global studies.
Attendees will learn:
- How early planning and flexible supply models help ensure site readiness
-
Why centralized CAM oversight supports risk mitigation across regions
-
What tiered services can offer trials with varying scope or complexity
-
How regulatory alignment and supplier performance affect delivery reliability